Nifedipine in the management of preterm labor: A systematic review and metaanalysis

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 2, 2011, Pages 134.e1-134.e20

  Conde Agudelo, Agustn ^a   Romero, Roberto ^a,b   Kusanovic, Juan Pedro ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

calcium channel blocker; neonatal morbidity; pregnancy; premature birth; preterm birth; tocolysis; uterine contractility

Indexed keywords

ATOSIBAN; GLYCEROL 1,2 DINITRATE; INDOMETACIN; ISOXSUPRINE; MAGNESIUM SULFATE; NIFEDIPINE; PLACEBO; RITODRINE; TERBUTALINE;

BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TOCOLYSIS;

EID: 79551490993     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.11.038     Document Type: Article

References (79)

1. S. Beck, D. Wojdyla, and L. Say The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity Bull World Health Organ 88 2010 31 38
2. M. Heron, P.D. Sutton, J. Xu, S.J. Ventura, D.M. Strobino, and B. Guyer Annual summary of vital statistics: 2007 Pediatrics 125 2010 4 15
3. T.N. Raju Epidemiology of late preterm (near-term) births Clin Perinatol 33 2006 751 763
4. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Epidemiology and causes of preterm birth Lancet 371 2008 75 84
5. S. Saigal, and L.W. Doyle An overview of mortality and sequelae of preterm birth from infancy to adulthood Lancet 371 2008 261 269
6. American College of Obstetricians and Gynecologists Committee on Practice Bulletins ACOG practice bulletin no. 43: clinical management guidelines for obstetrician-gynecologists. May 2003. Management of preterm labor Obstet Gynecol 101 2003 1039 1047
7. S. Anotayanonth, N.V. Subhedar, P. Garner, J.P. Neilson, and S. Harigopal Betamimetics for inhibiting preterm labour Cochrane Database Syst Rev 4 2004 CD004352
8. C.A. Crowther, J.E. Hiller, and L.W. Doyle Magnesium sulphate for preventing preterm birth in threatened preterm labour Cochrane Database Syst Rev 4 2002 CD001060
9. J. King, V. Flenady, S. Cole, and S. Thornton Cyclo-oxygenase (COX) inhibitors for treating preterm labour Cochrane Database Syst Rev 2 2005 CD001992
10. R. Romero, B.M. Sibai, and L. Sanchez-Ramos An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue Am J Obstet Gynecol 182 2000 1173 1183
11. S. Thornton, T.M. Goodwin, G. Greisen, M. Hedegaard, and J.C. Arce The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial Am J Obstet Gynecol 200 2009 627.e1 627.e10
12. K. Duckitt, and S. Thornton Nitric oxide donors for the treatment of preterm labour Cochrane Database Syst Rev 3 2002 CD002860
13. G.N. Smith, Y. Guo, S.W. Wen, M.C. Walker Canadian Preterm Labor Nitroglycerin Trial Group Secondary analysis of the use of transdermal nitroglycerin for preterm labor Am J Obstet Gynecol 203 2010 565.e1 565.e6
14. G.N. Smith, M.C. Walker, A. Ohlsson, K. O'Brien, R. Windrim Canadian Preterm Labour Nitroglycerin Trial Group Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor Am J Obstet Gynecol 196 2007 37.e1 37.e8
15. J.M. Dodd, C.A. Crowther, M.R. Dare, and P. Middleton Oral betamimetics for maintenance therapy after threatened preterm labour Cochrane Database Syst Rev 1 2006 CD003927
16. C.A. Crowther, and V. Moore Magnesium for preventing preterm birth after threatened preterm labour Cochrane Database Syst Rev 2 2000 CD000940
17. G.J. Valenzuela, L. Sanchez-Ramos, and R. Romero Maintenance treatment of preterm labor with the oxytocin antagonist atosiban The Atosiban PTL-098 Study Group Am J Obstet Gynecol 182 2000 1184 1190
18. V. Tsatsaris, D. Papatsonis, F. Goffinet, G. Dekker, and B. Carbonne Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis Obstet Gynecol 97 2001 840 847
19. J.F. King, V. Flenady, D. Papatsonis, G. Dekker, and B. Carbonne Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine Aust N Z J Obstet Gynaecol 43 2003 192 198
20. H.N. Simhan, and S.N. Caritis Prevention of preterm delivery N Engl J Med 357 2007 477 487
21. J.F. King, V.J. Flenady, D.N. Papatsonis, G.A. Dekker, and B. Carbonne Calcium channel blockers for inhibiting preterm labour Cochrane Database Syst Rev 1 2003 CD002255
22. N.N. Gaunekar, and C.A. Crowther Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour Cochrane Database Syst Rev 3 2004 CD004071
23. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 2009 W65 W94
24. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
25. Deeks JJ, Higgins JPT, Altman DG, eds. Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration; 2009.
26. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
27. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analyses detected by a simple graphical test BMJ 315 1997 629 634
28. D.G. Altman Confidence intervals for the number needed to treat BMJ 317 1998 1309 1312
29. M.D. Read, and D.E. Wellby The use of a calcium antagonist (nifedipine) to suppress preterm labour Br J Obstet Gynaecol 93 1986 933 937
30. J.E. Ferguson 2nd, D.C. Dyson, T. Schutz, and D.K. Stevenson A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome Am J Obstet Gynecol 163 1990 105 111
31. E. Janky, J.J. Leng, P.H. Cormier, R. Salamon, and J. Meynard A randomized study of the treatment of threatened premature labor Nifedipine versus ritodrine [in French] J Gynecol Obstet Biol Reprod (Paris) 19 1990 478 482
32. L.A. Bracero, E. Leikin, N. Kirshenbaum, and N. Tejani Comparison of nifedipine and ritodrine for the treatment of preterm labor Am J Perinatol 8 1991 365 369
33. M. Kupferminc, J.B. Lessing, Y. Yaron, and M.R. Peyser Nifedipine versus ritodrine for suppression of preterm labour Br J Obstet Gynaecol 100 1993 1090 1094
34. D.N. Papatsonis, H.P. Van Geijn, H.J. Adr, F.M. Lange, O.P. Bleker, and G.A. Dekker Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial Obstet Gynecol 90 1997 230 234
35. C.A. Koks, H.A. Brlmann, M.J. de Kleine, and P.A. Manger A randomized comparison of nifedipine and ritodrine for suppression of preterm labor Eur J Obstet Gynecol Reprod Biol 77 1998 171 176
36. J.A. Garca-Velasco, and A. Gonzlez Gonzlez A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor Int J Gynaecol Obstet 61 1998 239 244
37. K.M. Ganla, S.A. Shroff, S. Desail, and A.G. Bhinde a prospective comparison of nifedipine and isoxsuprine for tocolysis Bombay Hosp J 41 1999 259 262
38. F. Al-Qattan, A.E. Omu, and N. Labeeb A prospective randomized study comparing nifedipine versus ritodrine for the suppression of preterm labour Med Principles Pract 9 2000 164 173
39. W. Weerakul, A. Chittacharoen, and S. Suthutvoravut Nifedipine versus terbutaline in management of preterm labor Int J Gynaecol Obstet 76 2002 311 313
40. R. Rayamajhi, and K. Pratap A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour Kathmandu Univ Med J 1 2003 85 90
41. V. Cararach, M. Palacio, and S. Martnez Nifedipine versus ritodrine for suppression of preterm labor Comparison of their efficacy and secondary effects Eur J Obstet Gynecol Reprod Biol 127 2006 204 208
42. N. Laohapojanart, S. Soorapan, T. Wacharaprechanont, and C. Ratanajamit Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor J Med Assoc Thai 90 2007 2461 2469
43. L. Mawaldi, P. Duminy, and H. Tamim Terbutaline versus nifedipine for prolongation of pregnancy in patients with preterm labor Int J Gynaecol Obstet 100 2008 65 68
44. M. Van De Water, E.T. Kessel, M.J. De Kleine, and S.G. Oei Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial Acta Obstet Gynecol Scand 87 2008 340 345
45. J.L. Glock, and W.J. Morales Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study Am J Obstet Gynecol 169 1993 960 964
46. R.C. Floyd, B.N. McLaughlin, K.G. Perry Jr, R.W. Martin, C.A. Sullivan, and J.C. Morrison Magnesium sulfate or nifedipine hydrochloride for acute tocolysis of preterm labor: efficacy and side effects J Matern Fetal Invest 5 1995 25 29
47. L. Haghighi Prevention of preterm delivery: nifedipine or magnesium sulfate Int J Gynaecol Obstet 66 1999 297 298
48. A.A. Taherian, and P. Dehdar Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor J Res Med Sci 12 2007 136 142
49. D.J. Lyell, K. Pullen, and L. Campbell Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial Obstet Gynecol 110 2007 61 67
50. M. Kashanian, A.R. Akbarian, and M. Soltanzadeh Atosiban and nifedipine for the treatment of preterm labor Int J Gynaecol Obstet 91 2005 10 14
51. M.M. Amorim, L.A. Lippo, A.A. Costa, I.C. Coutinho, and A.S. Souza Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial [in Portuguese] Rev Bras Ginecol Obstet 31 2009 552 558
52. D.B. Carr, A.L. Clark, K. Kernek, and J.A. Spinnato Maintenance oral nifedipine for preterm labor: a randomized clinical trial Am J Obstet Gynecol 181 1999 822 827
53. N.C. Sayin, F.G. Varol, P. Balkanli-Kaplan, and M. Sayin Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor J Perinat Med 32 2004 220 224
54. D.J. Lyell, K.M. Pullen, and J. Mannan Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial Obstet Gynecol 112 2008 1221 1226
55. D.N. Papatsonis, J.H. Kok, H.P. van Geijn, O.P. Bleker, H.J. Adr, and G.A. Dekker Neonatal effects of nifedipine and ritodrine for preterm labor Obstet Gynecol 95 2000 477 481
56. B.A. Houtzager, S.M. Hogendoorn, and D.N. Papatsonis Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour BJOG 113 2006 324 331
57. B. Gonik, and R.K. Creasy Preterm labor: its diagnosis and management Am J Obstet Gynecol 154 1986 3 8
58. S.G. Oei, S.K. Oei, and H.A. Brlmann Myocardial infarction during nifedipine therapy for preterm labor N Engl J Med 340 1999 154
59. D. Verhaert, and R. Van Acker Acute myocardial infarction during pregnancy Acta Cardiol 59 2004 331 339
60. H.P. van Geijn, J.E. Lenglet, and A.C. Bolte Nifedipine trials: effectiveness and safety aspects BJOG 112 Suppl 1 2005 79 83
61. R. Hodges, A. Barkehall-Thomas, and C. Tippett Maternal hypoxia associated with nifedipine for threatened preterm labour BJOG 111 2004 380 381
62. A.J. van Veen, M.J. Pelinck, M.G. van Pampus, and J.J. Erwich Severe hypotension and fetal death due to tocolysis with nifedipine BJOG 112 2005 509 510
63. R. Parasuraman, M.M. Gandhi, and N.H. Liversedge Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion BJOG 113 2006 844 845
64. R. de Heus, B.W. Mol, and J.J. Erwich Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study BMJ 338 2009 b744
65. K. Khan, J. Zamora, and R.F. Lamont Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis J Matern Fetal Neonatal Med 23 2010 1030 1038
66. R. Romero, M. Mazor, H. Munoz, R. Gomez, M. Galasso, and D.M. Sherer The preterm labor syndrome Ann N Y Acad Sci 734 1994 414 429
67. R. Romero, D.T. Brody, and E. Oyarzun Infection and labor. III. Interleukin-1: a signal for the onset of parturition Am J Obstet Gynecol 160 1989 1117 1123
68. R. Romero, R. Gomez, and F. Ghezzi A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition Am J Obstet Gynecol 179 1998 186 193
69. R. Gomez, R. Romero, F. Ghezzi, B.H. Yoon, M. Mazor, and S.M. Berry The fetal inflammatory response syndrome Am J Obstet Gynecol 179 1998 194 202
70. C.J. Kim, R. Romero, and J.P. Kusanovic The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth Mod Pathol 23 2010 1000 1011
71. M.J. Kim, R. Romero, and C.J. Kim Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease J Immunol 182 2009 3919 3927
72. B.H. Yoon, R. Romero, and J.B. Moon Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes Am J Obstet Gynecol 185 2001 1130 1136
73. D.B. DiGiulio, R. Romero, and H.P. Amogan Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation PLoS One 3 2008 e3056
74. R. Romero, J.P. Kusanovic, and F. Gotsch Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation J Matern Fetal Neonatal Med 23 2010 261 280
75. R. Romero, S. Mazaki-Tovi, and E. Vaisbuch Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery J Matern Fetal Neonatal Med 23 2010 1344 1359
76. L. Pereira, A.P. Reddy, and A.L. Alexander Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor Am J Obstet Gynecol 202 2010 555.e1 555.e10
77. E. Hayes, L. Moroz, L. Pizzi, and J. Baxter A cost decision analysis of 4 tocolytic drugs Am J Obstet Gynecol 197 2007 383.e1 383.e6
78. G.C. Di Renzo, L.C. Roura European Association of Perinatal Medicine-Study Group on Preterm Birth Guidelines for the management of spontaneous preterm labor J Perinat Med 34 2006 359 366
79. B. Opmeer, S. Vijgen, and B.W. Mol Assessment of Perinatal Outcome with Sustained Tocolysis in Early Labor (APOSTEL) Am J Obstet Gynecol 204 2011 S2